Smokeless Tobacco Cessation
8
1
1
7
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 8 trials
100.0%
+13.5% vs benchmark
0%
0 trials in Phase 3/4
29%
2 of 7 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 7 completed trials
Clinical Trials (8)
A Text-based Reduction Intervention for Smokeless Tobacco Cessation- Pilot Study
Smokeless Tobacco Cessation Intervention for Firefighters
Testing ANSOS for Efficacy in Multi-Tribal Urban Communities
A Text-based Reduction Intervention for Smokeless Tobacco Cessation
Comparing Nicotine Delivery, Subjective Effects, and Sensory Experiences of Tobacco Users Using Oral Nicotine Products and Electronic Cigarettes [ZYN Study]
Nicotine Lozenges and Assisted Self-help for Smokeless Tobacco Cessation
Addressing Tobacco Use Disparities Through an Innovative Mobile Phone Intervention
Improvement in Knowledge and Perception About Hazards of Smokeless Tobacco